SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________


 
 

FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

________________
 


Date of Report (Date of earliest event reported):
October 30, 2006

 

Alpharma Inc.
 

(Exact name of registrant as specified in its charter)
 

Delaware
(State or other jurisdiction of incorporation)

1-8593
(Commission File
Number)

22-2095212
(IRS Employer Identification)
 
 

One Executive Drive, Fort Lee, New Jersey 07024
(Address of principal executive offices) (Zip Code)
 

Registrant's telephone number, including area code
(201) 947-7774
 
 

Not Applicable

______________________________________________
(Former name or former address, if changed since

last report)

Item 2.02. Results of Operations and Financial Condition

On October 30, 2006, Alpharma Inc. issued a press release announcing its financial results for the quarter ended September 30, 2006. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statement and Exhibits

(c) Exhibits.

99.1  Press release issued by Alpharma Inc. on October 30, 2006.

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 
 

ALPHARMA INC.
 

By: /s/ Jeffrey Campbell
 

Jeffrey Campbell
Interim Chief Financial Officer

Date: October 30, 2006